验证数据展示
经过测试的应用
Positive WB detected in | K-562 cells, HeLa cells |
Positive IHC detected in | human ovary cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:3000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
29663-1-AP targets MADD in WB, IHC, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, IHC, ELISA Application Description |
经测试反应性 | human |
免疫原 | MADD fusion protein Ag31292 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | MAP-kinase activating death domain |
别名 | MAP kinase-activating death domain protein, KIAA0358, IG20, FLJ36300, FLJ35600 |
计算分子量 | 1544 aa, 171 kDa |
观测分子量 | 200-250 kDa |
GenBank蛋白编号 | BC040484 |
基因名称 | MADD |
Gene ID (NCBI) | 8567 |
RRID | AB_3086151 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q8WXG6 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
MADD, MAP kinase-activating death domain protein, belongs to the DENN family, which regulates the Rab family is small GTPases (PMID: 20937701, PMID: 18559336). MADD plays a role in synaptic vesicle formation and in vesicle trafficking at the neuromuscular junction. MADD is also involved in TNFA-mediated activation of the MAPK pathway, including ERK1/2 (PMID: 32761064). KIF1Bβ- and KIF1A-mediated axonal transport of presynaptic regulator Rab3 occurs in a GTP-dependent manner through MADD (PMID: 18849981).
实验方案
Product Specific Protocols | |
---|---|
WB protocol for MADD antibody 29663-1-AP | Download protocol |
IHC protocol for MADD antibody 29663-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |